Mameniskis Algird R MD is categorized under Health Practitioners in Philadelphia, PA and active since 2001.
Mameniskis Algird R MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Practitioners business, which does work in the B2B market, and is classified as a Health Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Algird Mameniskis at the company’s single location by writing to 255 South 17th St # 300, Philadelphia, Pennsylvania PA 19103 or by phoning (215) 545-1918. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mameniskis Algird R MD |
| Contact Person: | Algird Mameniskis |
| Address: | 255 South 17th St # 300, Philadelphia, Pennsylvania 19103 |
| Phone Number: | (215) 545-1918 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Health Practitioners |
| SIC Code: | 8049 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mameniskis Algird R MD was started in 2001 to provide professional Health Practitioners under the SIC code 8049 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Algird Mameniskis for inquiries that concern Mameniskis Algird R MD by calling the company number (215) 545-1918, as your correspondence is most welcome. Additionally, the physical location of the single location of Mameniskis Algird R MD can be found at the coordinates 39.948204,-75.169397 as well as the street address 255 South 17th St # 300 in Philadelphia, Pennsylvania 19103.
For its online presence, you may visit Mameniskis Algird R MD’s website at and engage with its social media outlets through on Twitter and on Facebook.